
Traded Value【Hong Kong IPO】Xizhi, did everyone get an allocation?
Hello, I'm Hertz.
I. Listing Situation
None
II. Grey Market Situation
None
III. Allotment Results
The allotment results for Xizhi and Mewei have been announced.
$XIZHI TECH-P(01879.HK)
Group A was a full lottery, Group B heads were guaranteed 1 and could get 2, Group B heads had a big win.(Some will definitely say Group B heads have double the capital of Group A tails, so it's a complete win; but if Group A tails get nothing, that's a goose egg, at least Group B heads can't get nothing);
This round, I split the Xizhi Group B head and went for Shangmi. Luckily, the Xizhi Group A tail got 1, otherwise it would have been a big loss. Getting Xizhi wasn't too hard, many small capital accounts got some. Next, we wait for Guanglai. See you in the grey market, doubling shouldn't be a problem.
$MABWELL-B(02493.HK)
Priced at 27.64 (27.64~30.71), priced at the lower end;
350 lots guaranteed 1 lot. Actually, for small capital, this was harder to get than Xizhi. My cash and free margin applications all got nothing;
400 lots ~ Group A tail, guaranteed 1, got 2; Group B heads guaranteed 2, top hammer 11 lots.
Mewei's A-shares have fallen for two consecutive days recently. Luckily, it was priced at the lower end. The current discount rate is 35.27%(as of the close on April 24th). Having a sip of soup shouldn't be a big problem.
(This is just personal experience sharing and does not constitute investment advice. For reference only.)
IV. IPO Subscription
A new IPO launched on Friday, $STAR SPORTS MED(01609.HK) .
Let's first look at the basic information.
The number of lots issued is not high, only 16,840 lots, which is very few. Detailed article analysis will be in the next issue.
(This is just personal experience sharing and does not constitute investment advice. For reference only.)
⚠️ Disclaimer: Some materials in this article are sourced from public networks, and the copyright belongs to the original author. The content is compiled based on public information and is for reference only, not constituting any investment advice. Investment involves risks, participation requires caution. The targets mentioned in the article are only personal operation records and do not constitute investment advice. We are not responsible for any losses incurred from such investments!
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
